Drug Diversion Webinar Series #3: Crisis Control - How to Handle Unwarranted HCP Diversion at Your Hospital
•
1 like•556 views
Nobody expects diversion to happen at their hospital, and when it does, it can be a complex challenge to confront. Kim New and other special guests discuss how to effectively manage diversion incidents when they occur. The priorities are to minimize risk, protect patient safety, and help rehabilitate the diverter. Kim is a leading national expert on drug diversion. As a former compliance specialist at the University of Tennessee Medical Center, Kim became an expert in catching, managing, and ultimately minimizing drug diversion incidents.
Recommended
More Related Content
What's hot
What's hot (20)
Similar to Drug Diversion Webinar Series #3: Crisis Control - How to Handle Unwarranted HCP Diversion at Your Hospital
Similar to Drug Diversion Webinar Series #3: Crisis Control - How to Handle Unwarranted HCP Diversion at Your Hospital (20)
Recently uploaded
Recently uploaded (20)
Drug Diversion Webinar Series #3: Crisis Control - How to Handle Unwarranted HCP Diversion at Your Hospital
- 1. © 2014 Omnicell, Inc. Crisis Control: How to Handle Unwarranted HCP Diversion at Your Hospital Kimberly S. New JD BSN RN
- 2. © 2014 Omnicell, Inc. Diversion •Diversion can’t be prevented entirely •Facilities must prevent what they can, detect diversion quickly and respond appropriately •It is essential that response efforts be comprehensive and consistent © K New 2014
- 3. © 2014 Omnicell, Inc. Look for a Pattern Million dollar question: “When do I have enough evidence to intervene?” Knowing what isn’t diversion is just as important as knowing what is! © K New 2014
- 4. © 2014 Omnicell, Inc. Consider Developing a Packet •Checklist •Steps and decision tree •Key numbers •Forms •Relevant policies
- 5. © 2014 Omnicell, Inc. Keeping Patients Safe When reasonable suspicion exists: •Remove the suspected individual from patient contact •Ensure drug cabinet access is discontinued •If appropriate, suspend physical access © K New 2014
- 6. © 2014 Omnicell, Inc. Reasonable Suspicion •Team approach •Managers need support •Have experienced team members •Notify relevant VPs and others (security) prior to confronting suspected staff member © K New 2014
- 7. © 2014 Omnicell, Inc. Diversion Team •Nursing •Pharmacy •Diversion Specialist •Human Resources •Supervisor •Security •Risk Management © K New 2014
- 8. © 2014 Omnicell, Inc. Reasonable Suspicion •Initial interview of suspected staff member, including review of medical record and drug cabinet records •Drug screen •Suspension pending conclusion of investigation © K New 2014
- 9. © 2014 Omnicell, Inc. Interview •Extremely important step in determining what has happened •Keep the group small •One person should take the lead and conduct the interview •Others should not offer input unless necessary •Goal is to allow the suspected staff member to explain © K New 2014
- 10. © 2014 Omnicell, Inc. Interview •Ensure that interview occurs in location that affords suspected diverter privacy •Environment should be quiet and free of distractions •Anticipate possible explanations © K New 2014
- 11. © 2014 Omnicell, Inc. Testing Explanations I’m just not good at documenting/I was too busy to chart •Is it just a controlled medication or the suspected drug of choice that isn’t documented? © K New 2014
- 12. © 2014 Omnicell, Inc. Testing Explanations I’m not good at wasting •Is failure to waste limited to a particular drug? •Look at historical data to see if this a consistent issue over time © K New 2014
- 13. © 2014 Omnicell, Inc. Testing Explanations I dropped a pill/vial and forgot to waste/The patient spit it out (duplicate doses) •Look for duplicate non-controlled drug withdrawals •Check timing of administration © K New 2014
- 14. © 2014 Omnicell, Inc. Have on Hand •Employee training records •Time records •Relevant discrepancy reports •Information about peer performance on similar measures © K New 2014
- 15. © 2014 Omnicell, Inc. Key Questions •Tampering/substitution •Patients denied pain relief •Medications in locker, bag or at home •Duration, drugs, methods •Personal use or sale © K New 2014
- 16. © 2014 Omnicell, Inc. Drug Screen •Input from those with knowledge of investigation •Consider methods available/most appropriate •Make sure drug screen is observed •Have a plan for “after hours” testing © K New 2014
- 17. © 2014 Omnicell, Inc. Consider Bloodborne Pathogen Testing •Offer bloodborne pathogen testing with drug screen •Choice of any or all: hep b, hep c, HIV •Fair treatment regardless of choice •Results to Occ Med and only to Infection Prevention and regional Health Dept if a positive result is obtained © K New 2014
- 18. © 2014 Omnicell, Inc. Interview •Plan for confession •Plan for impairment •Ensure safety of all involved © K New 2014
- 19. © 2014 Omnicell, Inc. Employee Disposition 21 CFR 1301.92 Illicit activities by employees •Employees who possess, sell, use or divert controlled substances will subject themselves not only to State or Federal prosecution •Employer will immediately determine status of continued employment by assessing the seriousness of the violation, the position of responsibility held by the employee, past record of employment, etc. © Kim New 2014
- 20. © 2014 Omnicell, Inc. Internal and External Reporting •42 CFR 482.25(b)(7) - Abuses and losses of controlled substances must be reported, in accordance with applicable Federal and State laws, to the individual responsible for the pharmaceutical service, and to the chief executive officer, as appropriate © Kim New 2014
- 21. © 2014 Omnicell, Inc. Internal and External Reporting •VP over the relevant department •Diversion Committee •Human Resources •Risk Management/General Counsel •Security •Pharmacy •Finance © K New 2014
- 22. © 2014 Omnicell, Inc. Internal and External Reporting •DEA (Form 106) •State Licensure Board and/or Professional Assistance •Department of Health (patient harm issues and/or possible bloodborne pathogen exposure) •Law Enforcement/AG Office - crimes, issues of abuse/neglect/reckless endangerment, fraud •Pharmacy Board •Institutional Infection Prevention Dept © Kim New 2014
- 23. © 2014 Omnicell, Inc. Root Cause Analysis TJC MM.08.01.01 The hospital evaluates the effectiveness of its medication management system: •Analyze data •Keep up with best practices •Identify and implement improvement measures •Re-evaluate system © Kim New 2014
- 24. © 2014 Omnicell, Inc. Root Cause Analysis 42 CFR 482.25(b)(2)(i-ii) •If tampering or diversion occurs, or if medication security otherwise becomes a problem, the hospital must evaluate its current medication control policies and procedures, and implement the necessary systems and processes to ensure that the problem is corrected, and that patient health and safety are maintained © Kim New 2014
- 25. © 2014 Omnicell, Inc. Sharing Experiences with Relevant Leadership Groups •Behaviors that may have preceded recognition •Methods •Unique considerations •Take-aways
- 26. © 2014 Omnicell, Inc. Conclusion •Because diversion can’t be prevented entirely, having a plan is essential •Ensure a consistent and comprehensive approach •Document all efforts •Analyze each event to maximize opportunities for performance improvement © K New 2014
- 27. © 2014 Omnicell, Inc. Speaker: Kimberly New, JD BSN RN (865) 456-1813 Kim_New@zoho.com Omnicell Contact: Jose Castanon, MBA Director, Product Marketing (650) 251-6010 jose.castanon@omnicell.com Upcoming Diversion Webinar: Webinar 4: December 2, 2014 Save Lives, Money, and Reputation – Take the Driver’s Seat on Medication Diversion Additional Presentations at the ASHP Midyear 2014: •Intelligent Pharmacy Pavilion, Tuesday December 9th, 2:20 PM •Omnicell Exhibit, Booth #589 Omnicell Pharmacy Leadership Meeting at ASHP: •Sunday December 7th, 4:00 PM, Register Online: http://www.omnicell.com/PLM Register at www.omnicell.com/TLSWebinars Questions?